Literature DB >> 10976705

Basal cell carcinoma: clues to its presence in histologic sections when the initial slide is nondiagnostic.

H M Haupt1, J B Stern, M S Dilaimy.   

Abstract

Initial sections of skin biopsies may not be diagnostic of basal cell carcinoma (BCC). Are there histologic predictors of BCC that should prompt deeper sections? Ninety-four cases in which the clinical diagnosis was BCC or "rule-out BCC," and the initial histologic slides were nondiagnostic, were submitted for deeper sections on three additional slides. Of the 94 cases, 50 (53%) demonstrated BCC on deeper sections. This relatively high incidence suggests that deeper sections should be taken in all cases of clinically suspected BCCs unless alternate histologic findings adequately account for the clinical lesion. The results of this study suggest that additional sections are more likely to yield BCC when the initial nondiagnostic slide demonstrates focal epidermal atypia, equivocal adnexae, stromal fibrosis, empty dermal space, and microcalcifications, criteria which may be useful in determining the need to do deeper sections in cases in which BCC is not clinically suspected.

Entities:  

Mesh:

Year:  2000        PMID: 10976705     DOI: 10.1097/00000478-200009000-00014

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  3 in total

1.  Dermal changes in superficial basal cell carcinoma, melanoma in situ and actinic keratosis and their implications.

Authors:  Viktoryia Kazlouskaya; Saurabh Malhotra; Raquel Navarro; Karen Nguyen Wu; Marianna Shvartsbeyn; Chen Shengli; Jiang Gui; Dirk M Elston
Journal:  J Cutan Pathol       Date:  2013-10-03       Impact factor: 1.587

Review 2.  [Basal cell carcinoma and rare form variants].

Authors:  J Liersch; J Schaller
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

Review 3.  Usefulness of Photodynamic Therapy as a Possible Therapeutic Alternative in the Treatment of Basal Cell Carcinoma.

Authors:  Paola Savoia; Tommaso Deboli; Alberto Previgliano; Paolo Broganelli
Journal:  Int J Mol Sci       Date:  2015-09-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.